BOZEMAN, MT, and VANCOUVER, BC--(Marketwired - August 04, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, specializing in the ...
BOZEMAN, MT and VANCOUVER, BC--(Marketwired - May 26, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that the U.S.
BOZEMAN, MT and VANCOUVER, BC--(Marketwired - March 01, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that ...
BOZEMAN, Mont. and VANCOUVER, BC, Feb. 22, 2021 /PRNewswire/ — Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC (“Microbion”) today announced that it has received ...
Microbion Corporation, a clinical-stage pharmaceutical company developing a new class of therapeutic compounds to improve the lives of patients with rare and serious diseases, announced that the ...
BOZEMAN, Mont. and VANCOUVER, British Columbia, Oct. 25, 2019 /PRNewswire/ -- Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced that the ...
Pravibismane is the first of a new class of drugs with broad-spectrum potency against a wide range of pathogens, including NTM species Poster presentation highlighted the results from pravibismane in ...
Phase 2 study assesses safety and efficacy of topical pravibismane in subjects suffering from moderate infections associated with chronic diabetic foot ulcers In a previous Phase 1b randomized, double ...
BOZEMAN, MT, and VANCOUVER, BC--(Marketwired - June 16, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, specializing in the ...